-- Days : -- HRS : -- MIN : -- SEC

Register Now →

Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Michael Naslund, MD, MBA

Articles by Michael Naslund, MD, MBA

Cost Comparison of Finasteride and Dutasteride for Enlarged Prostate in a Managed Care Setting Among Medicare-aged Men

ByMichael Naslund, MD, MBA,Michael T. Eaddy, PharmD, PhD,Eric J. Kruep, PharmD, MS,Susan L. Hogue, PharmD, MPH

May 1st 2008

5-Alpha Reductase Inhibitors in Men With an Enlarged Prostate: An Evaluation of Outcomes and Therapeutic Alternatives

ByMichael Naslund, MD, MBA,Timothy S. Regan, BPharm, RPh, CPh,Christine Ong, PharmD, MBA, BS,Susan L. Hogue, PharmD, MPH

May 1st 2008

Differences in Alpha Blocker Usage Among Enlarged Prostate Patients Receiving Combination Therapy with 5 ARIs

ByMichael Naslund, MD, MBA,Libby Black, PharmD,Michael Eaddy, PharmD, PhD,LaKeasha R. Batiste, MS

February 1st 2007

Latest Updated Articles

Trending on AJMC

CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes

ATTR-CM Incidence, Prevalence Rose Sharply in the US

FDA Approves Palbociclib for HR+, HER2+ Breast Cancer Maintenance

First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention

Mixed Phase 3 Results for IB6-Targeting ADC Raise Questions on Optimal Use in NSCLC